Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a Week-Long retreat boost Well-Being after cancer?

NCT ID NCT07398079

First seen Mar 13, 2026 · Last updated Jun 19, 2026 · Updated 9 times

Summary

This pilot study will test whether a 7-day integrative oncology retreat called 'Via Shalva' is feasible and helpful for women who have finished primary treatment for breast or gynecologic cancer. The retreat includes personalized consultations, complementary therapies, and group mind-body activities. Researchers will measure quality of life, stress, and other health markers in 30 participants, comparing them to a matched group receiving usual care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University Hospital Basel

    RECRUITING

    Basel, 4031, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Integrative Cure Stay retreat (behavioral intervention)

What this could lead to

If successful, this could show that a short retreat combining complementary therapies and mind-body practices improves quality of life for cancer survivors.

What could go wrong

This is a very small pilot study (30 participants) with no blinding or randomization, so results may not be reliable or generalizable. The retreat is not a treatment for cancer itself.

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm female reproductive organ cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.